SEC EDGAR · Financial report
BMY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
Follow BMY- Became public
- Jul 30, 2026, 11:10 AM EDT
- Event / period date
- Jun 30, 2026
- Collected
- Nov 10, 2026, 12:26 PM EST
Why this is connected
This filing identifies BRISTOL MYERS SQUIBB CO as the issuer of the security. The company's SEC identifier connects it to BMY.
Source evidence
Read the source excerpt or record
bmy-20260630 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 10-Q ___________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Commission File Number 001-01136 ___________________________ BRISTOL-MYERS SQUIBB COMPANY (Exact name of registrant as specified in its charter) ___________________________ Delaware 22-0790350 (State or other jurisdiction of incorporation or organization) ( I.R.S. Employer Identification No.) Route 206 & Province Line Road , Princeton , New Jersey 08543 (Address of principal executive offices) (Zip Code) ( 609 ) 252-4621 ( Registrant’s telephone number, including area code ) ___________________________ (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 Par Value BMY New York Stock Exchange Celgene Contingent Value Rights CELG RT New York Stock Exchange 2.973% Notes due 2030 BMY/30 New York Stock Exchange 3.363% Notes due 2033 BMY/33 New York Stock Exchange 1.750% Notes due 2035 BMY35 New York Stock Exchange 3.857% Notes due 2038 BMY/38 New York Stock Exchange 4.289% Notes due 2045 BMY/45 New York Stock Exchange 4.581% Notes due 2055 BMY/55 New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such sh
Congressional trading in BMY
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 13, 2026 · disclosed Nov 5, 2026 · Spouse
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 11, 2026$15K–$50K
Rep. Mike Kelly (R-PA-16)
Sold Bristol-Myers Squibb Company BMY
$15K–$50K · Traded May 7, 2026 · disclosed Jun 11, 2026 · Spouse
Got $3K from the company’s PAC - Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
Sold Bristol-Myers Squibb Company BMY
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 15, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 15, 2026 · Joint
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Apr 28, 2025 · disclosed Jan 13, 2026 · filed 260 days later
Got $2K from the company’s PAC - Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 23, 2024 · disclosed Jan 13, 2026 · filed 447 days later
Got $2K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.